EUVIMEDEUVIMED entdecken
Crossref

DOES OLANZAPINE-INDUCED OBESITY CAUSE PATHOLOGICAL CHANGES IN THE ESOPHAGEAL MUCOSA OF ANIMALS?

M.A. Shchetinin, A.A. Kotvytska, K.V. Tikhonovych, M.V. Bilets, O.Y. Omelchenko, D.O. Khmil, K.S. Neporada

Fiziolohichnyĭ zhurnal · 24.03.2026 · 72 (02) · 57-64

DOI: 10.15407/fz72.02.057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fiziolohichnyĭ zhurnal, online erschienen am 24.03.2026. Verfasst von M.A. Shchetinin und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent experimental and clinical studies have expanded the understanding of the mechanisms underlying metabolic and gastrointestinal adverse effects of olanzapine, an atypical antipsychotic widely used in the treatment of psychotic disorders and associated with the development of obesity. The present study aimed to elucidate the mechanisms of pathological changes in the esophageal mucosa of rats under conditions of administration of different doses of olanzapine. A total of 15 male rats were included and randomly assigned to experimental groups. Biochemical parameters of the esophageal mucosa were assessed, including the content of glycosaminoglycans (GAGs), free fucose, hydroxyproline, thiobarbituric acid-reactive substances (TBARS), oxidatively modified proteins (OMP), as well as the activity of catalase, proteinases, and their inhibitors. It was found that endogastric administration of olanzapine at doses of 4 mg/kg and 8 mg/kg body weight resulted in the development of visceral obesity, as evidenced by a significant increase in body mass index, Lee index, and visceral fat mass in experimental animals compared with intact controls. Analysis of changes in the esophageal mucosa revealed that olanzapine-induced visceral obesity led to the activation of free radical processes, as indicated by a significant increase in the levels of OMP and TBARS compared to intact animals. Additionally, a significant increase in GAGs, hydroxyproline, and free fucose content in the esophageal mucosa of experimental rats was observed compared with the control group, indicating enhanced catabolism of glycoproteins and proteoglycans in the connective tissue of the rat esophagus. Thus, the use of atypical antipsychotics, particularly olanzapine, contributes to the development of oxidative stress, activation of proteolysis, and intensified degradation of fucoproteins, proteoglycans, and collagen proteins of the esophagus.

Zitieren

APA

Shchetinin, M., Kotvytska, A., Tikhonovych, K., Bilets, M., Omelchenko, O., Khmil, D., & Neporada, K. (2026). DOES OLANZAPINE-INDUCED OBESITY CAUSE PATHOLOGICAL CHANGES IN THE ESOPHAGEAL MUCOSA OF ANIMALS?. Fiziolohichnyĭ zhurnal, 72(02), 57-64. https://doi.org/10.15407/fz72.02.057

Vancouver

Shchetinin M, Kotvytska A, Tikhonovych K, Bilets M, Omelchenko O, Khmil D, et al. DOES OLANZAPINE-INDUCED OBESITY CAUSE PATHOLOGICAL CHANGES IN THE ESOPHAGEAL MUCOSA OF ANIMALS?. Fiziolohichnyĭ zhurnal. 2026;72(02):57-64. doi:10.15407/fz72.02.057

BibTeX
@article{Shchetinin2026,
  author = {Shchetinin, M.A. and Kotvytska, A.A. and Tikhonovych, K.V. and Bilets, M.V. and Omelchenko, O.Y. and Khmil, D.O. and Neporada, K.S.},
  title = {DOES OLANZAPINE-INDUCED OBESITY CAUSE PATHOLOGICAL CHANGES IN THE ESOPHAGEAL MUCOSA OF ANIMALS?},
  journal = {Fiziolohichnyĭ zhurnal},
  year = {2026},
  volume = {72},
  number = {02},
  pages = {57--64},
  doi = {10.15407/fz72.02.057}
}
Kostenlos starten →